Stocks and Investing
Stocks and Investing
Tue, November 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $133 on, Nov 27th, 2023
Robert Burns of HC Wainwright & Co., Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $133 on, Nov 27th, 2023.
Robert has made no other calls on BNTX in the last 4 months.
There are 2 other peers that have a rating on BNTX. Out of the 2 peers that are also analyzing BNTX, all agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Wednesday, November 8th, 2023
- Yifeng Liu of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $111 on, Monday, October 16th, 2023
Contributing Sources